Search Results - "Charoo, Naseem A."

Refine Results
  1. 1

    Risk-Based Approach for Defining Retest Dates for Active Pharmaceutical Ingredients and Excipients by Charoo, Naseem A, Akanji, Omotayo, Rahman, Ziyaur, Khan, Aqeel A, Badshah, Aqal

    Published in Pharmaceuticals (Basel, Switzerland) (07-07-2024)
    “…Drug substances and excipients must be stored in recommended storage conditions and should comply with their specifications during the retest period for their…”
    Get full text
    Journal Article
  2. 2

    Data integrity issues in pharmaceutical industry: Common observations, challenges and mitigations strategies by Charoo, Naseem A., Khan, Mansoor A., Rahman, Ziyaur

    Published in International journal of pharmaceutics (25-01-2023)
    “…[Display omitted] Data integrity (DI) reaffirms the pharmaceutical industry's commitment to manufacture drugs that are safe, effective and fulfil quality…”
    Get full text
    Journal Article
  3. 3

    Selective laser sintering 3D printing - an overview of the technology and pharmaceutical applications by Charoo, Naseem A., Barakh Ali, Sogra F., Mohamed, Eman M., Kuttolamadom, Mathew A., Ozkan, Tanil, Khan, Mansoor A., Rahman, Ziyaur

    Published in Drug development and industrial pharmacy (02-06-2020)
    “…Food and Drug Administration (FDA) has approved a drug product (Spritam®) and many medical devices manufactured by three-dimensional printing (3DP) processes…”
    Get full text
    Journal Article
  4. 4

    Nitroso Impurities in Drug Products: An Overview of Risk Assessment, Regulatory Milieu, and Control Strategy by Charoo, Naseem A., Dharani, Sathish, Khan, Mansoor A., Rahman, Ziyaur

    Published in AAPS PharmSciTech (09-02-2023)
    “…Many nitrosamines have been recognized to be carcinogenic for many decades. Despite the fact that several nitrosamine precursors are frequently used in the…”
    Get full text
    Journal Article
  5. 5

    Additive Manufacturing with 3D Printing: Progress from Bench to Bedside by Rahman, Ziyaur, Barakh Ali, Sogra F., Ozkan, Tanil, Charoo, Naseem A., Reddy, Indra K., Khan, Mansoor A.

    Published in The AAPS journal (01-11-2018)
    “…Three-dimensional (3D) printing was discovered in the 1980s, and many industries have embraced it, but the pharmaceutical industry is slow or reluctant to…”
    Get full text
    Journal Article
  6. 6

    In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil by Rahman, Ziyaur, Kohli, Kanchan, Zhang, Shuang-Qing, Khar, Roop K., Ali, Mushir, Charoo, Naseem A., Tauseef, Mohammad, Shamsher, Areeg A. A., Mohammed, Noorullah N., Repka, Michael A.

    Published in Journal of pharmacy and pharmacology (01-05-2008)
    “…The aims of this investigation were to determine the distribution in the gastrointestinal (GI) tract of Eudragit S‐100 encapsulated colon‐specific sodium…”
    Get full text
    Journal Article
  7. 7

    Exploratory Investigation of the Limiting Steps of Oral Absorption of Fluconazole and Ketoconazole in Children Using an In Silico Pediatric Absorption Model by Cristofoletti, Rodrigo, Charoo, Naseem A, Dressman, Jennifer B

    Published in Journal of pharmaceutical sciences (01-09-2016)
    “…Due to the higher total clearance of certain drugs in children than in adults, it is recommended that, in such cases, higher relative doses on a…”
    Get more information
    Journal Article
  8. 8

    Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Levocetirizine Dihydrochloride by Charoo, Naseem A, Abdallah, Daud B, Ahmed, Daoud T, Abrahamsson, Bertil, Cristofoletti, Rodrigo, Langguth, Peter, Mehta, Mehul, Parr, Alan, Polli, James E, Shah, Vinod P, Kambayashi, Atsushi, Dressman, Jennifer

    Published in Journal of pharmaceutical sciences (01-04-2023)
    “…Levocetirizine, a histamine H1-receptor antagonist, is prescribed to treat uncomplicated skin rashes associated with chronic idiopathic urticaria as well as…”
    Get more information
    Journal Article
  9. 9

    Quality by design approach for formulation development: A case study of dispersible tablets by Charoo, Naseem A., Shamsher, Areeg A.A., Zidan, Ahmed S., Rahman, Ziyaur

    Published in International journal of pharmaceutics (28-02-2012)
    “…The focus of the current investigations was to apply quality by design (QbD) approach to the development of dispersible tablets. Critical material and process…”
    Get full text
    Journal Article
  10. 10

    Is the demonstration of bioequivalence for clavulanic acid required in amoxicillin–clavulanic acid orally administered immediate‐release products? by Charoo, Naseem A., Rahman, Ziyaur, Ali, Areeg Anwer

    Published in Journal of pharmacy and pharmacology (01-07-2018)
    “…Objectives Bioequivalence (BE) criteria for amoxicillin–clavulanic acid (Co‐amoxiclav) oral formulations are based on 90% confidence interval for both…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Pharmaceutical product development: A quality by design approach by Pramod, Kannissery, Tahir, M, Charoo, Naseem, Ansari, Shahid, Ali, Javed

    “…The application of quality by design (QbD) in pharmaceutical product development is now a thrust area for the regulatory authorities and the pharmaceutical…”
    Get full text
    Journal Article
  13. 13

    Integrating biopharmaceutics risk assessment and in vivo absorption model in formulation development of BCS class I drug using the QbD approach by Charoo, Naseem A., Cristofoletti, Rodrigo, Kim, Sun K.

    Published in Drug development and industrial pharmacy (03-04-2017)
    “…Objective: Clinically relevant critical quality attributes (CQA's) were identified for the development of generic drug products containing fluconazole and…”
    Get full text
    Journal Article
  14. 14

    Risk assessment for extending the Biopharmaceutics Classification System-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric population by Charoo, Naseem A., Cristofoletti, Rodrigo, Dressman, Jennifer B.

    Published in Journal of pharmacy and pharmacology (01-08-2015)
    “…Objectives The paediatric population undergoes developmental changes in gastric pH, gastric emptying, intestinal transit time, membrane permeability, protein…”
    Get full text
    Journal Article
  15. 15

    Ophthalmic Delivery of Ciprofloxacin Hydrochloride from Different Polymer Formulations: In Vitro and In Vivo Studies by Charoo, Naseem A., Kohli, Kanchan, Ali, Asgar, Anwer, Areeg

    Published in Drug development and industrial pharmacy (01-01-2003)
    “…Abstract Reservoir-type ocular inserts were fabricated using sodium alginate containing ciprofloxacin hydrochloride as the core (drug reservoir) that was…”
    Get full text
    Journal Article
  16. 16

    Biowaiver monograph for immediate-release solid oral dosage forms: bisoprolol fumarate by Charoo, Naseem A, Shamsher, Areeg A A, Lian, Lai Y, Abrahamsson, Bertil, Cristofoletti, Rodrigo, Groot, D W, Kopp, Sabine, Langguth, Peter, Polli, James, Shah, Vinod P, Dressman, Jennifer

    Published in Journal of pharmaceutical sciences (01-02-2014)
    “…Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate-release (IR) solid oral dosage…”
    Get more information
    Journal Article
  17. 17

    Characterization of 5-fluorouracil microspheres for colonic delivery by Rahman, Ziyaur, Kohli, Kanchan, Khar, Roop K., Ali, Mushir, Charoo, Naseem A., Shamsher, Areeg A. A.

    Published in AAPS PharmSciTech (01-06-2006)
    “…The purpose of this investigation was to prepare and evaluate the colon-specific microspheres of 5-fluorouracil for the treatment of colon cancer. Core…”
    Get full text
    Journal Article
  18. 18

    Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations by Shamsher, Areeg A., Charoo, Naseem A., Rahman, Ziyaur, Pillai, Krishna K., Kohli, Kanchan

    Published in Pharmaceutical development and technology (01-02-2014)
    “…Abstract The focus of the present study was to develop and evaluate the transdermal system of celecoxib. Transdermal gels composed of carbopol 940 in propylene…”
    Get full text
    Journal Article
  19. 19

    Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies by Charoo, Naseem A, Kohli, Kanchan, Ali, Asgar

    Published in Journal of pharmaceutical sciences (01-02-2003)
    “…Sol-to-gel systems of ciprofloxacin hydrochloride were prepared utilizing the phase transition properties of hydroxy propyl methyl cellulose K 15 M grade…”
    Get more information
    Journal Article
  20. 20

    Herbal and prescription weight loss products: awareness among pharmacists about efficacy and safety by Shamsher, Areeg A. A., Nadeem, Nada, Nadeem, Verda, Mutib, Khawla O., Mutib, Nasiba O., Charoo, Naseem A.

    Published in Journal of pharmacy practice and research (01-12-2016)
    “…Background Weight loss medications that were traditionally considered safe and effective are associated with severe adverse effects. Aim The present work seeks…”
    Get full text
    Journal Article